Warrants
Warrants
As part of the loan agreement between Faron Pharmaceuticals and IPF Partners in 2022, Faron granted IPF Partners 319,944 warrants. Each 2022 warrant entitles its holder to subscribe for one new share in the company and is exercisable for seven years from 25 March 2022. The exercise price for each 2022 warrant is EUR 1.00 (status 31 December 2024).
In 2024, Faron granted IPF Partners warrants as follows:
- A total of 667,066 warrants, exercisable for seven years starting from March 27, 2024. Each warrant entitles its holder to subscribe for one new share of the company. The subscription price for these warrants is EUR 1.00 (as of December 31, 2024).
- Additionally, 333,333 warrants that are exercisable for seven years starting from May 17, 2024. Each warrant entitles its holder to subscribe for one new share of the company. The subscription price is EUR 1.00 (as of December 31, 2024).
| Warrantholder | Number of warrants issued | Date of issuance | Valid until | Subscription price, EUR |
| IPF Fund II SCA, SICAV-FIAR | 319,944 | 28 February 2022 | 25 March 2029 | 1.00 |
| IPF Fund II SCA, SICAV-FIAR | 613,496 | 27 March 2024 | 27 March 2031 | 1.00 |
| 53,570 | 3 April 2024 | 3 April 2031 | 1.00 | |
| IPF Fund II SCA, SICAV-FIAR | 333,333 | 17 May 2024 | 17 May 2031 | 1.00 |
More information about the warrants can be found below.
The information above is disclosed in accordance with Rule 26 of the AIM Rules for Companies.